The Institute of Molecular and Oncological Medicine of Asturias (IMOMA) is a private company which was created in spring, 2008, to fight against cancer. The joint venture was formed by Corporación Masaveu, Liberbank (Cajastur) and Medicina Asturiana. Our aim is to offer patients the best possible tools available to prevent and overcome this disease.
Our healthcare programme is based on three main pillars: 1) coordinated, up-to-date, personalized patient care, 2) the integration of the latest developments in molecular biology in our clinical protocols and 3) cutting edge radiotherapy.
IMOMA is a medical facility, owned by Corporación Masaveu, which controls 66% of the shareholding via its affiliate Masaveu Medicina, and its participated company Medicina Asturiana-Centro Médico. Liberbank holds the remaining 33%.
IMOMA can be found very near to Oviedo, in the Centro Médico de Asturias Healthcare Complex. IMOMA's Radiotherapy Unit covers an area of 1300m2, the building houses the "TrueBeam STx Powered by Novalis" lineal accelerator as well as consulting rooms and bunkers for planning and delivering external radiotherapy. IMOMA's Laboratory of Molecular Medicine and additional consulting rooms are located in the main building of the Healthcare Complex.